|
|
Volumn 13, Issue 15, 1999, Pages 2188-2189
|
|
The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy [14]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ANTIRETROVIRUS AGENT;
C PEPTIDE;
GLUCOSE;
INSULIN;
LAMIVUDINE;
LIPID;
NEVIRAPINE;
PYRUVIC ACID;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ZIDOVUDINE;
BODY FAT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG WITHDRAWAL;
GLUCOSE BLOOD LEVEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INSULIN BLOOD LEVEL;
LETTER;
LIPID BLOOD LEVEL;
LIPODYSTROPHY;
MALE;
METABOLIC DISORDER;
PRIORITY JOURNAL;
ANTI-HIV AGENTS;
BODY COMPOSITION;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HUMANS;
LIPODYSTROPHY;
MALE;
PROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
STAVUDINE;
|
|
EID: 0032710644
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-199910220-00035 Document Type: Letter |
|
Times cited : (79)
|
|
References (5)
|
